720 related articles for article (PubMed ID: 23850816)
1. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
Zhang Y; Zhi Z; Li X; Gao J; Song Y
Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
[TBL] [Abstract][Full Text] [Related]
2. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
3. Novel chitosan-functionalized spherical nanosilica matrix as an oral sustained drug delivery system for poorly water-soluble drug carvedilol.
Sun L; Wang Y; Jiang T; Zheng X; Zhang J; Sun J; Sun C; Wang S
ACS Appl Mater Interfaces; 2013 Jan; 5(1):103-13. PubMed ID: 23237208
[TBL] [Abstract][Full Text] [Related]
4. Poly dimethyl diallyl ammonium coated CMK-5 for sustained oral drug release.
Zhang C; Zhao Q; Wan L; Wang T; Sun J; Gao Y; Jiang T; Wang S
Int J Pharm; 2014 Jan; 461(1-2):171-80. PubMed ID: 24300214
[TBL] [Abstract][Full Text] [Related]
5. Mesoporous carbon as a novel drug carrier of fenofibrate for enhancement of the dissolution and oral bioavailability.
Niu X; Wan L; Hou Z; Wang T; Sun C; Sun J; Zhao P; Jiang T; Wang S
Int J Pharm; 2013 Aug; 452(1-2):382-9. PubMed ID: 23688621
[TBL] [Abstract][Full Text] [Related]
6. The mechanism for increasing the oral bioavailability of poorly water-soluble drugs using uniform mesoporous carbon spheres as a carrier.
Wang T; Zhao P; Zhao Q; Wang B; Wang S
Drug Deliv; 2016; 23(2):420-8. PubMed ID: 24870199
[TBL] [Abstract][Full Text] [Related]
7. Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica.
Mellaerts R; Mols R; Jammaer JA; Aerts CA; Annaert P; Van Humbeeck J; Van den Mooter G; Augustijns P; Martens JA
Eur J Pharm Biopharm; 2008 May; 69(1):223-30. PubMed ID: 18164930
[TBL] [Abstract][Full Text] [Related]
8. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
[TBL] [Abstract][Full Text] [Related]
9. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
Li T; Geng T; Md A; Banerjee P; Wang B
Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
[TBL] [Abstract][Full Text] [Related]
10. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.
Zhang Y; Wang J; Bai X; Jiang T; Zhang Q; Wang S
Mol Pharm; 2012 Mar; 9(3):505-13. PubMed ID: 22217205
[TBL] [Abstract][Full Text] [Related]
11. Increasing the dissolution rate and oral bioavailability of the poorly water-soluble drug valsartan using novel hierarchical porous carbon monoliths.
Zhang Y; Che E; Zhang M; Sun B; Gao J; Han J; Song Y
Int J Pharm; 2014 Oct; 473(1-2):375-83. PubMed ID: 25051114
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of mesoporous carbon/lipid bilayer nanocomposites for improved oral delivery of the poorly water-soluble drug, nimodipine.
Zhang Y; Zhao Q; Zhu W; Zhang L; Han J; Lin Q; Ai F
Pharm Res; 2015 Jul; 32(7):2372-83. PubMed ID: 25609013
[TBL] [Abstract][Full Text] [Related]
13. Carvedilol nano lipid carriers: formulation, characterization and in-vivo evaluation.
Mishra A; Imam SS; Aqil M; Ahad A; Sultana Y; Ameeduzzafar ; Ali A
Drug Deliv; 2016 May; 23(4):1486-94. PubMed ID: 26978072
[TBL] [Abstract][Full Text] [Related]
14. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
Kumar D; Sailaja Chirravuri SV; Shastri NR
Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel core-shell structured dual-mesoporous silica nanospheres and their application for enhancing the dissolution rate of poorly water-soluble drugs.
Wu C; Sun X; Zhao Z; Zhao Y; Hao Y; Liu Y; Gao Y
Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():262-7. PubMed ID: 25280705
[TBL] [Abstract][Full Text] [Related]
16. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
17. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
Yan YD; Sung JH; Kim KK; Kim DW; Kim JO; Lee BJ; Yong CS; Choi HG
Int J Pharm; 2012 Jan; 422(1-2):202-10. PubMed ID: 22085435
[TBL] [Abstract][Full Text] [Related]
18. Highly ordered mesoporous carbon nanomatrix as a new approach to improve the oral absorption of the water-insoluble drug, simvastatin.
Zhang Y; Wang H; Gao C; Li X; Li L
Eur J Pharm Sci; 2013 Aug; 49(5):864-72. PubMed ID: 23791638
[TBL] [Abstract][Full Text] [Related]
19. A Comparative Study of the Use of Mesoporous Carbon and Mesoporous Silica as Drug Carriers for Oral Delivery of the Water-Insoluble Drug Carvedilol.
Han C; Huang H; Dong Y; Sui X; Jian B; Zhu W
Molecules; 2019 May; 24(9):. PubMed ID: 31067732
[TBL] [Abstract][Full Text] [Related]
20. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol.
Wang Y; Sun L; Jiang T; Zhang J; Zhang C; Sun C; Deng Y; Sun J; Wang S
Drug Dev Ind Pharm; 2014 Jun; 40(6):819-28. PubMed ID: 23594300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]